Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Impact of abiraterone acetate plus prednisone in patients with castration-sensitive prostate cancer and visceral metastases over four years of follow-up: A post-hoc exploratory analysis of the LATITUDE studyEur. J. Cancer 2021 Dec 22;162(xx)56-64, G Baciarello, M Özgüroğlu, S Mundle, G Leitz, U Richarz, P Hu, S Feyerabend, N Matsubara, KN Chi, K Fizazi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.